NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.

Hussein BA, Kristenson L, Pesce S, Wohr A, Tian Y, Hallner A, Brune M, Hellstrand K, Tang KW, Bernson E, Thoren FB
J Immunother Cancer. 2023 Aug;11(8):e007202. doi: 10.1136/jitc-2023-007202. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.